Should Patents on Pharmaceuticals Be Extended to Encourage Innovation?

By ACSH Staff — Jan 23, 2012
Related content:
OxyContin(ues)- The FDA gets it right4/17/13
How Big Pharma Uses Logically Impossible Patents to Block Innovation
The Supreme Court nails it (and Myriad) No, you cannot patent a gene
Government Is The Big Reason EpiPen And Other Generics Are So Expensive
Gene patents OK, higher court rules
Josh Bloom, Wall Street Journal 1/23/12 Should Patents on Pharmaceuticals Be Extended to Encourage Innovation?

Josh Bloom, Wall Street Journal 1/23/12

Should Patents on Pharmaceuticals Be Extended to Encourage Innovation?

ACSH Staff

Recent articles by this author:
Fukushima's Tritiated Water
Investigation: Scientology-Linked Lawyers Spread Lies About Vaccines and GMOs, Attack Scientists
ACSH, Paul Thacker, and His 'Thacker of Trolls'
Why a Vaccine Can Provide Better Immunity than an Actual Infection
Perchlorate in Drinking Water
All articles by this author
ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles

ACSH Podcasts

Latest from Henry

Latest from Josh

Latest from Chuck